Becton Dickinson & Co (BDX)
224.04
-1.40
(-0.62%)
USD |
NYSE |
Nov 22, 16:00
224.04
0.00 (0.00%)
After-Hours: 16:21
Becton Dickinson Revenue (Annual): 20.18B for Sept. 30, 2024
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
September 30, 2024 | 20.18B |
September 30, 2023 | 19.37B |
September 30, 2022 | 18.87B |
September 30, 2021 | 19.13B |
September 30, 2020 | 16.07B |
September 30, 2019 | 17.29B |
September 30, 2018 | 15.98B |
September 30, 2017 | 12.09B |
September 30, 2016 | 12.48B |
September 30, 2015 | 10.28B |
September 30, 2014 | 8.446B |
September 30, 2013 | 8.054B |
September 30, 2012 | 7.708B |
September 30, 2011 | 7.584B |
September 30, 2010 | 7.124B |
September 30, 2009 | 6.987B |
September 30, 2008 | 7.075B |
September 30, 2007 | 6.360B |
September 30, 2006 | 5.738B |
September 30, 2005 | 5.415B |
September 30, 2004 | 4.935B |
Date | Value |
---|---|
September 30, 2003 | 4.464B |
September 30, 2002 | 3.960B |
September 30, 2001 | 3.754B |
September 30, 2000 | 3.618B |
September 30, 1999 | 3.418B |
September 30, 1998 | 3.117B |
September 30, 1997 | 2.810B |
September 30, 1996 | 2.770B |
September 30, 1995 | 2.712B |
September 30, 1994 | 2.560B |
September 30, 1993 | 2.465B |
September 30, 1992 | 2.365B |
September 30, 1991 | 2.172B |
September 30, 1990 | 2.013B |
September 30, 1989 | 1.812B |
September 30, 1988 | 1.709B |
September 30, 1987 | 1.582B |
September 30, 1986 | 1.312B |
September 30, 1985 | 1.144B |
September 30, 1984 | 1.127B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
16.07B
Minimum
2020
20.18B
Maximum
2024
18.72B
Average
19.13B
Median
2021
Revenue (Annual) Benchmarks
Boston Scientific Corp | 14.24B |
Abbott Laboratories | 40.11B |
Baxter International Inc | 14.81B |
Merit Medical Systems Inc | 1.257B |
ResMed Inc | 4.685B |